Create Medicines
MA - CambridgeBiotechnology
Focus: Create Medicines is a publicly traded biotechnology company headquartered in Cambridge, MA, specializing in cell therapy for cancer with a focus on in vivo CAR-T programs. With 5,000+ employees, it operates at significant scale within the competitive oncology cell therapy space.
Profile data last refreshed 9h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Employees
5000+
Open Jobs
0
About Create Medicines
AI assessmentNot HiringNo open roles listed right now. Follow Create Medicines to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Create Medicines's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
MT-303
Hepatocellular CarcinomaClinical Trials (1)
NCT06478693A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
Phase 1Help build intelligence for Create Medicines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.